 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 7 | 1/1 | 返回列表 |
| 查看: 2287 | 回復(fù): 6 | ||
[求助]
求助格列美脲片的質(zhì)量標(biāo)準(zhǔn)
|
|
求助格列美脲片的質(zhì)量標(biāo)準(zhǔn) 或者其他國(guó)家的藥典相關(guān)內(nèi)容（格列美脲片的質(zhì)量標(biāo)準(zhǔn)）！�。� [ 來(lái)自科研家族 木蟲有機(jī) ] |
回復(fù)此樓» 猜你喜歡
材料專碩英一數(shù)二306
已經(jīng)有6人回復(fù)
-
265求調(diào)劑
已經(jīng)有4人回復(fù)
-
265求調(diào)劑
已經(jīng)有7人回復(fù)
-
26調(diào)劑/材料/英一數(shù)二/總分289/已過(guò)A區(qū)線
已經(jīng)有8人回復(fù)
-
281求調(diào)劑（0805）
已經(jīng)有21人回復(fù)
-
0817 化學(xué)工程 299分求調(diào)劑 有科研經(jīng)歷 有二區(qū)文章
已經(jīng)有20人回復(fù)
-
279分求調(diào)劑 一志愿211
已經(jīng)有6人回復(fù)
-
085600材料與化工 求調(diào)劑
已經(jīng)有17人回復(fù)
-
能源材料化學(xué)課題組招收碩士研究生8-10名
已經(jīng)有13人回復(fù)
-
317求調(diào)劑
已經(jīng)有6人回復(fù)
» 本主題相關(guān)價(jià)值貼推薦，對(duì)您同樣有幫助:
- 【求助】壓片過(guò)程中怎么控制片重具體為多少克？？
已經(jīng)有13人回復(fù)
- 【求助】鹽酸地爾硫卓緩釋片的質(zhì)量標(biāo)準(zhǔn)
已經(jīng)有3人回復(fù)
- 【求助】大家有誰(shuí)知道哪些含磷表面活性劑可以和MMT相容，并且插到MMT片層間？
已經(jīng)有4人回復(fù)
- 【求助】求助：鹽酸氨基葡萄糖片質(zhì)量標(biāo)注，小弟新手
已經(jīng)有9人回復(fù)
- 【求助】哪位高人用過(guò)偏振分光片，請(qǐng)教！
已經(jīng)有6人回復(fù)
- 【求助】蘭索拉唑腸溶片溶出度問(wèn)題
已經(jīng)有9人回復(fù)
zwj959
木蟲 (小有名氣)
- 應(yīng)助: 5 (幼兒園)
- 金幣: 3766.2
- 帖子: 183
- 在線: 188.5小時(shí)
- 蟲號(hào): 1046341
- 注冊(cè): 2010-06-23
- 性別: MM
- 專業(yè): 藥劑學(xué)
【答案】應(yīng)助回帖
申建宇(金幣+2): 2011-10-18 12:57:58
|
藥品標(biāo)準(zhǔn)查詢數(shù)據(jù)庫(kù)（Drug Standard Database）藥品名稱 標(biāo)準(zhǔn)來(lái)源 頁(yè)碼 標(biāo)準(zhǔn)號(hào) 標(biāo)準(zhǔn)全文 格列美脲片 新藥轉(zhuǎn)正標(biāo)準(zhǔn)第74冊(cè) 147 格列美脲片 新藥轉(zhuǎn)正標(biāo)準(zhǔn)第67冊(cè) 180 格列美脲片 新藥轉(zhuǎn)正標(biāo)準(zhǔn)第51冊(cè) 167 PDF 格列美脲片(亞莫利) 進(jìn)口藥品復(fù)核標(biāo)準(zhǔn)匯編2000年P(guān)154,P157,P160(1-640頁(yè)為上冊(cè)),中檢所進(jìn)口藥品復(fù)核標(biāo)準(zhǔn)(12)NO728 JX19990344 格列美脲片 FSDA下發(fā)的進(jìn)口注冊(cè)標(biāo)準(zhǔn)(4) NO211 JX20020305 ©2011 DrugFuture->Drug Standard Database |
2樓2011-10-18 10:23:14
癡夷子皮
版主 (文壇精英)
老痞
- PhEPI: 10
- 應(yīng)助: 2016 (講師)
- 貴賓: 5.368
- 金幣: 54487.3
- 散金: 41688
- 紅花: 303
- 沙發(fā): 1206
- 帖子: 32611
- 在線: 4303.7小時(shí)
- 蟲號(hào): 674536
- 注冊(cè): 2008-12-14
- 性別: GG
- 專業(yè): 無(wú)神論
- 管轄: 人文社科
【答案】應(yīng)助回帖
申建宇(金幣+3): 2011-10-18 12:57:48
申建宇(金幣+2): 2011-10-18 12:58:12
申建宇(金幣+3): 2011-10-24 17:10:48
申建宇(金幣+2): 2011-10-18 12:58:12
申建宇(金幣+3): 2011-10-24 17:10:48
|
USP32–NF27 Page 2498 Glimepiride Tablets » Glimepiride Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of glimepiride (C24H34N4O5S). Packaging and storage— Preserve in well-closed containers. Store at controlled room temperature. USP Reference standards 11— USP Glimepiride RS . USP Glimepiride Related Compound B RS . USP Glimepiride Related Compound C RS . Identification— The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay. Uniformity of dosage units 905: meet the requirements. Related compounds— [note—Store the solutions containing glimepiride for no longer than 24 hours.] Mobile phase and Diluent— Prepare as directed in the Assay. System suitability solution— Prepare a solution in Diluent containing about 0.04 mg of USP Glimepiride RS per mL and about 0.02 mg each of USP Glimepiride Related Compound B RS and USP Glimepiride Related Compound C RS per mL. Pipet a 5.0-mL aliquot of this solution into a 50-mL volumetric flask, dilute with Diluent to volume, and mix. Sensitivity solution— Pipet a 5.0-mL aliquot of the System suitability solution into a 100-mL volumetric flask, dilute with Diluent to volume, and mix. Test solution— Weigh and finely powder not fewer than 10 Tablets, and transfer an accurately weighed portion of the powder to a 50-mL centrifuge tube. Add Diluent to prepare a solution containing about 0.1 mg of glimepiride per mL, based on the label claim. Sonicate in a water bath at a temperature not to exceed 20 for not less than 5 minutes and not more than 10 minutes, with occasional mixing. Centrifuge the samples, and use the clear supernatant. Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 228-nm detector and a 4-mm × 25-cm column that contains packing L1. The flow rate is about 1 mL per minute. Chromatograph the System suitability solution, and identify the glimepiride peak and the peaks due to the related compounds on the basis of the relative retention times, which are about 0.2 for glimepiride related compound B, about 0.3 for glimepiride related compound C, and 1.0 for glimepiride. Record the peak responses as directed for Procedure: the resolution, R, between glimepiride related compounds B and C is not less than 4, and the relative standard deviation of the glimepiride peak for replicate injections is not more than 2.0%. Chromatograph the Sensitivity solution, and calculate the signal-to-noise ratio, S/N, for the peaks of glimepiride related compounds B and C by the formula: (2H)/h in which H is the measured height of the respective related compound peak, and h is the amplitude of the average measured baseline noise. The S/N for each peak is not less than 10. Procedure— Inject a volume (about 10 µL) of the Test solution into the chromatograph, record the chromatograms, and measure the peak responses. Continue the elution for at least two times the retention time of the glimepiride peak. Calculate the percentage of each impurity in the portion of Tablets taken by the formula: 100(1 / F)(rU / rs) in which F is the relative response factor, which is equal to 1.3 for glimepiride related compound B and 1.0 for any other impurity; rU is the peak response for each impurity obtained from the Test solution; and rs is the sum of the responses of all the peaks in the Test solution. Disregard any peak less than 0.1%. Not more than 2.5% of glimepiride related compound B is found, not more than 0.5% of any other individual impurity is found, not more than 1.0% of total impurities excluding glimepiride related compound B is found, and not more than 3.5% of overall total impurities (including glimepiride related compound B) is found. Assay— [note—Store the solutions containing glimepiride no longer than 24 hours.] Mobile phase— Dissolve 0.5 g of monobasic sodium phosphate in 500 mL of water. Adjust with 10% phosphoric acid to a pH of 2.1 to 2.7, add 500 mL of acetonitrile, and mix. Diluent— Prepare a mixture of acetonitrile and water (9:1). System suitability preparation— Prepare a solution in Diluent containing 0.1 mg of USP Glimepiride RS per mL and 0.02 mg each of USP Glimepiride Related Compound B RS and USP Glimepiride Related Compound C RS per mL. Standard preparation— Dissolve an accurately weighed quantity of USP Glimepiride RS in Diluent to obtain a solution having a known concentration of about 0.1 mg per mL. Assay preparation— Transfer five whole Tablets into a suitable volumetric flask to prepare a solution of approximately 0.1 mg of glimepiride per mL, based on the label claim. Add water to 10% of the volume of the flask. Shake the flask to completely dissolve the tablets. Add acetonitrile to about 70% of the volume of the flask, and swirl. Sonicate the samples in a water bath not to exceed 20 for not less than 5 minutes and not more than 10 minutes with occasional shaking. Allow the solutions to come to room temperature, dilute with acetonitrile to volume, mix, and filter. Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 228-nm detector and a 4-mm × 12.5-cm column that contains packing L1. The flow rate is about 1 mL per minute. Chromatograph the System suitability preparation, and identify the glimepiride peak and the peaks due to the related compounds based on their relative retention times, which are about 0.25 for glimepiride related compound B, about 0.35 for glimepiride related compound C, and 1.0 for glimepiride. Record the peak responses as directed for Procedure: the resolution, R, between glimepiride related compounds B and C is not less than 1.5, and the tailing factor for the glimepiride peak is not more than 2.0. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the relative standard deviation for replicate injections is not more than 2.0%. Procedure— Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the areas for the major peaks. Calculate the percentage of the labeled amount of glimepiride (C24H34N4O5S) in the portion of Tablets taken by the formula: 100(CS / CU)(rU / rS) in which CS is the concentration, in mg per mL, of glimepiride in the Standard preparation; CU is the concentration of glimepiride in the Assay preparation, based on the labeled quantity per Tablet and the extent of dilution; and rU and rS are the peak responses for glimepiride obtained from the Assay preparation and the Standard preparation, respectively. |
3樓2011-10-18 10:33:50
癡夷子皮
版主 (文壇精英)
老痞
- PhEPI: 10
- 應(yīng)助: 2016 (講師)
- 貴賓: 5.368
- 金幣: 54487.3
- 散金: 41688
- 紅花: 303
- 沙發(fā): 1206
- 帖子: 32611
- 在線: 4303.7小時(shí)
- 蟲號(hào): 674536
- 注冊(cè): 2008-12-14
- 性別: GG
- 專業(yè): 無(wú)神論
- 管轄: 人文社科
無(wú)法修改了。 4樓2011-10-18 10:36:12
癡夷子皮
版主 (文壇精英)
老痞
- PhEPI: 10
- 應(yīng)助: 2016 (講師)
- 貴賓: 5.368
- 金幣: 54487.3
- 散金: 41688
- 紅花: 303
- 沙發(fā): 1206
- 帖子: 32611
- 在線: 4303.7小時(shí)
- 蟲號(hào): 674536
- 注冊(cè): 2008-12-14
- 性別: GG
- 專業(yè): 無(wú)神論
- 管轄: 人文社科
5樓2011-10-18 11:44:08
yaopinbiao
鐵蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 24.7
- 帖子: 7
- 在線: 1小時(shí)
- 蟲號(hào): 1477968
- 注冊(cè): 2011-11-05
6樓2011-11-05 22:46:46
丁丁up
金蟲 (小有名氣)
- 應(yīng)助: 7 (幼兒園)
- 金幣: 2494.5
- 帖子: 115
- 在線: 66.1小時(shí)
- 蟲號(hào): 305558
- 注冊(cè): 2006-12-10
- 性別: MM
- 專業(yè): 藥劑學(xué)
7樓2012-06-04 09:32:40
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 申建宇 的主題更新
| 7 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 能源材料化學(xué)課題組招收碩士研究生8-10名 +4 | 脫穎而出 2026-03-16 | 13/650 |
|
|---|---|---|---|---|
|
[考研] 材料學(xué)碩318求調(diào)劑 +5 | February_Feb 2026-03-19 | 5/250 |
|
|
|
[考研] 一志愿中國(guó)海洋大學(xué)，生物學(xué)，301分，求調(diào)劑 +5 | 1孫悟空 2026-03-17 | 6/300 |
|
|
|
[考研] 復(fù)試調(diào)劑 +4 | z1z2z3879 2026-03-14 | 6/300 |
|
|
|
[考研] 321求調(diào)劑 +8 | 何潤(rùn)采123 2026-03-18 | 10/500 |
|
|
|
[考研] 一志愿西安交通大學(xué)材料工程專業(yè) 282分求調(diào)劑 +5 | 楓橋ZL 2026-03-18 | 7/350 |
|
|
|
[考研] 材料考研調(diào)劑 +3 | xwt。 2026-03-19 | 3/150 |
|
|
|
[考研] 一志愿985，本科211，0817化學(xué)工程與技術(shù)319求調(diào)劑 +10 | Liwangman 2026-03-15 | 10/500 |
|
|
|
[考研] 0817調(diào)劑 +3 | 沒(méi)有答案_ 2026-03-14 | 3/150 |
|
|
|
[考研] 330求調(diào)劑 +3 | 小材化本科 2026-03-18 | 3/150 |
|
|
|
[考研] 299求調(diào)劑 +5 | △小透明* 2026-03-17 | 5/250 |
|
|
|
[考研] 280求調(diào)劑 +6 | 咕嚕曉曉 2026-03-18 | 7/350 |
|
|
|
[考研] 0703化學(xué)336分求調(diào)劑 +6 | zbzihdhd 2026-03-15 | 7/350 |
|
|
|
[考研] 有沒(méi)有道鐵/土木的想調(diào)劑南林，給自己招師弟中～ +3 | TqlXswl 2026-03-16 | 7/350 |
|
|
|
[考研] 一志愿，福州大學(xué)材料專碩339分求調(diào)劑 +3 | 木子momo青爭(zhēng) 2026-03-15 | 3/150 |
|
|
|
[考研] 0856求調(diào)劑 +3 | 劉夢(mèng)微 2026-03-15 | 3/150 |
|
|
|
[考研] 326求調(diào)劑 +3 | mlpqaz03 2026-03-15 | 3/150 |
|
|
|
[考研] 288求調(diào)劑 +4 | 奇點(diǎn)0314 2026-03-14 | 4/200 |
|
|
|
[考研] 中科大材料與化工319求調(diào)劑 +3 | 孟鑫材料 2026-03-14 | 3/150 |
|
|
|
[考研] 330求調(diào)劑 +3 | ?醬給調(diào)劑跪了 2026-03-13 | 3/150 |
|